Agohob, Nakia .

HRN: 22-24-33  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/25/2023
11/01/2023
IV
70mg
TID
TC Amoebiasis
Checking Final Appropriateness 
10/26/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/26/2023
11/01/2023
ORAL
1.9ml
TID
AGE
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: